Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stahl, J. S.
Right arrow Articles by Leigh, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stahl, J. S.
Right arrow Articles by Leigh, J. R.
NEUROLOGY 1998;51:1093-1099
© 1998 American Academy of Neurology

Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin

John S. Stahl, MD, PhD, Lea Averbuch-Heller, MD, Bernd F. Remler, MD and John R. Leigh, MD

From the Department of Neurology, University Hospitals of Cleveland and Cleveland Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH.

Address correspondence and reprint requests to Dr. John S. Stahl, Department of Neurology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106.

Objective: To compare the effects of botulinum toxin on static and dynamic aspects of eye movements, and thereby elucidate the mechanisms of its action on eye muscles.

Background: Laboratory evidence indicates that static alignment and saccades are subserved by different extraocular muscle fiber types, and botulinum toxin may cause specific dysfunction of the fibers controlling static alignment. Diplopia is a well-known side effect of periorbital botulinum toxin injections in humans, and may be a clinical correlate of the laboratory findings.

Methods: Search coil recording of eye movements was performed in one patient with systemic botulism, and in three patients with diplopia following periorbital injection of botulinum toxin A.

Results: In the patient with acute botulism, eye movement alignment, range, and saccadic velocity profiles were abnormal. In three patients with iatrogenic diplopia, static alignment was abnormal but movement range and saccadic velocities were within normal limits. Edrophonium improved the range of movements and saccadic velocities in the patient with systemic botulism but was ineffective in reversing ocular misalignment in the one iatrogenic patient to whom it was administered.

Conclusions: Precise alignment is subserved by orbital singly innervated muscle fibers, and the effects of botulinum toxin are greatest on these fibers. This predilection is apparent when the toxin dose is very small, as must have been the case in our patients with iatrogenic diplopia. The lack of a response to edrophonium probably reflects structural damage to muscle fibers. In contrast, larger doses of toxin produce an acute dysfunction of all extraocular muscle fiber types, which is responsive to edrophonium and consequently reflects partial blockade at the neuromuscular junction.


Supported by National Institutes of Health grants EY00356 and EY06717, the Department of Veterans Affairs, and the Evenor Armington Fund.

Received March 24, 1998. Accepted in final form June 6, 1998.




This article has been cited by other articles:


Home page
IOVSHome page
M. H. J. Wiesen, S. Bogdanovich, I. Agarkova, J.-C. Perriard, and T. S. Khurana
Identification and Characterization of Layer-Specific Differences in Extraocular Muscle M-Bands
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1119 - 1127.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. S. Stahl, R. A. James, B. S. Oommen, F. E. Hoebeek, and C. I. De Zeeuw
Eye Movements of the Murine P/Q Calcium Channel Mutant Tottering, and the Impact of Aging
J Neurophysiol, March 1, 2006; 95(3): 1588 - 1607.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Yin, J. S. Stahl, F. H. Andrade, C. A. McMullen, S. Webb-Wood, N. J. Newman, V. Biousse, D. C. Wallace, and M. T. Pardue
Eliminating the Ant1 Isoform Produces a Mouse with CPEO Pathology but Normal Ocular Motility
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4555 - 4562.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. Ugalde, S. P. Christiansen, and L. K. McLoon
Botulinum Toxin Treatment of Extraocular Muscles in Rabbits Results in Increased Myofiber Remodeling
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4114 - 4120.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. T. Budak, S. Bogdanovich, M. H. J. Wiesen, O. Lozynska, T. S. Khurana, and N. A. Rubinstein
Layer-specific differences of gene expression in extraocular muscles identified by laser-capture microscopy
Physiol Genomics, December 15, 2004; 20(1): 55 - 65.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. A. Rubinstein, J. D. Porter, and J. F. Y. Hoh
The Development of Longitudinal Variation of Myosin Isoforms in the Orbital Fibers of Extraocular Muscles of Rats
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3067 - 3072.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. A. McMullen, F. H. Andrade, and J. S. Stahl
Functional and Genomic Changes in the Mouse Ocular Motor System in Response to Light Deprivation from Birth
J. Neurosci., January 7, 2004; 24(1): 161 - 169.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. S. Kranjc, J. Sketelj, A. D'Albis, and I. Erzen
Long-Term Changes in Myosin Heavy Chain Composition after Botulinum Toxin A Injection into Rat Medial Rectus Muscle
Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3158 - 3164.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Varrato and S. Galetta
Fourth nerve palsy unmasked by botulinum toxin therapy for cervical torticollis
Neurology, September 26, 2000; 55(6): 896 - 896.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by AAN Enterprises, Inc.